NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82

Mar 17, 2016 08:18 IST

The National Research Development Corporation (NRDC) on 16 March 2016 signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an Ayurvedic formulation for prevention and management of diabetes.

The agreement will now allow Kudos Laboratories India to commercialize the drug under their trade name with due acknowledgement to Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Government of India.

Ayush-82 was developed by CCRAS. The CCRAS is an apex organization for research in Ayurveda under the Ministry of AYUSH.

About Kudos Laboratories India

Kudos Laboratories India, a 100 years old organization, is engaged in marketing, manufacturing and exports of the widest range of Ayurvedic / Herbal products and range of Cosmetics.

The company holds G.M.P & ISO Certifications.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

Is this article important for exams ? Yes12 People Agreed
Read more Current Affairs on: Kudos Laboratories India , NRDC , Ministry of AYUSH , Ayush-82 , Diabetes

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK